This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rong, S
Right arrow Articles by Vande Woude, G F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rong, S
Right arrow Articles by Vande Woude, G F

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 November; 12(11): 5152-5158

Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.

S Rong, M Bodescot, D Blair, J Dunn, T Nakamura, K Mizuno, M Park, A Chan, S Aaronson and G F Vande Woude

ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Maryland 21702.

ABSTRACT

The met proto-oncogene is the tyrosine kinase growth factor receptor for hepatocyte growth factor/scatter factor (HGF/SF). It was previously shown that, like the oncogenic tpr-met, the mouse met proto-oncogene transforms NIH 3T3 cells. We have established NIH 3T3 cells stably expressing both human (Methu) and mouse (Metmu) met proto-oncogene products. The protein products are properly processed and appear on the cell surface. NIH 3T3 cells express endogenous mouse HGF/SF mRNA, suggesting an autocrine activation mechanism for transformation by Metmu. However, the tumor-forming activity of Methu in NIH 3T3 cells is very low compared with that of Metmu, but efficient tumorigenesis occurs when Methu and HGF/SFhu are coexpressed. These results are consistent with an autocrine transformation mechanism and suggest further that the endogenous murine factor inefficiently activates the tumorigenic potential of Methu. The tumorigenicity observed with reciprocal chimeric human and mouse receptors that exchange external ligand-binding domains supports this conclusion. We also show that HGF/SFhu expressed in NIH 3T3 cells produces tumors in nude mice.

Mol Cell Biol. 1992 November; 12(11): 5152-5158




This article has been cited by other articles:

  • Yamazaki, S., Skaptason, J., Romero, D., Lee, J. H., Zou, H. Y., Christensen, J. G., Koup, J. R., Smith, B. J., Koudriakova, T. (2008). Pharmacokinetic-Pharmacodynamic Modeling of Biomarker Response and Tumor Growth Inhibition to an Orally Available cMet Kinase Inhibitor in Human Tumor Xenograft Mouse Models. Drug Metab. Dispos. 36: 1267-1274 [Abstract] [Full Text]  
  • Jin, H., Yang, R., Zheng, Z., Romero, M., Ross, J., Bou-Reslan, H., Carano, R. A.D., Kasman, I., Mai, E., Young, J., Zha, J., Zhang, Z., Ross, S., Schwall, R., Colbern, G., Merchant, M. (2008). MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival. Cancer Res. 68: 4360-4368 [Abstract] [Full Text]  
  • Myerburg, M. M., Latoche, J. D., McKenna, E. E., Stabile, L. P., Siegfried, J. S., Feghali-Bostwick, C. A., Pilewski, J. M. (2007). Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1352-L1360 [Abstract] [Full Text]  
  • Zou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., Nambu, M. D., Los, G., Bender, S. L., Mroczkowski, B., Christensen, J. G. (2007). An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms. Cancer Res. 67: 4408-4417 [Abstract] [Full Text]  
  • Stabile, L. P., Lyker, J. S., Land, S. R., Dacic, S., Zamboni, B. A., Siegfried, J. M. (2006). Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer. Carcinogenesis 27: 1547-1555 [Abstract] [Full Text]  
  • Zhou, H. Y., Wong, A. S. T. (2006). Activation of p70S6K Induces Expression of Matrix Metalloproteinase 9 Associated with Hepatocyte Growth Factor-Mediated Invasion in Human Ovarian Cancer Cells. Endocrinology 147: 2557-2566 [Abstract] [Full Text]  
  • Smolen, G. A., Muir, B., Mohapatra, G., Barmettler, A., Kim, W. J., Rivera, M. N., Haserlat, S. M., Okimoto, R. A., Kwak, E., Dahiya, S., Garber, J. E., Bell, D. W., Sgroi, D. C., Chin, L., Deng, C.-X., Haber, D. A. (2006). Frequent met oncogene amplification in a brca1/trp53 mouse model of mammary tumorigenesis.. Cancer Res. 66: 3452-3455 [Abstract] [Full Text]  
  • Chen, J.-T., Lin, T.-S., Chow, K.-C., Huang, H.-H., Chiou, S.-H., Chiang, S.-F., Chen, H.-C., Chuang, T.-L., Lin, T.-Y., Chen, C.-Y. (2006). Cigarette Smoking Induces Overexpression of Hepatocyte Growth Factor in Type II Pneumocytes and Lung Cancer Cells. Am. J. Respir. Cell Mol. Bio. 34: 264-273 [Abstract] [Full Text]  
  • Kim, K. J., Wang, L., Su, Y.-C., Gillespie, G. Y., Salhotra, A., Lal, B., Laterra, J. (2006). Systemic Anti-Hepatocyte Growth Factor Monoclonal Antibody Therapy Induces the Regression of Intracranial Glioma Xenografts. Clin. Cancer Res. 12: 1292-1298 [Abstract] [Full Text]  
  • Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., Daida, H. (2005). Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection. J. Virol. 79: 609-614 [Abstract] [Full Text]  
  • Shinomiya, N., Gao, C. F., Xie, Q., Gustafson, M., Waters, D. J., Zhang, Y.-W., Vande Woude, G. F. (2004). RNA Interference Reveals that Ligand-Independent Met Activity Is Required for Tumor Cell Signaling and Survival. Cancer Res. 64: 7962-7970 [Abstract] [Full Text]  
  • Schag, K., Schmidt, S. M., Muller, M. R., Weinschenk, T., Appel, S., Weck, M. M., Grunebach, F., Stevanovic, S., Rammensee, H.-G., Brossart, P. (2004). Identification of C-Met Oncogene as a Broadly Expressed Tumor-Associated Antigen Recognized by Cytotoxic T-Lymphocytes. Clin. Cancer Res. 10: 3658-3666 [Abstract] [Full Text]  
  • Yoshida, S., Harada, T., Mitsunari, M., Iwabe, T., Sakamoto, Y., Tsukihara, S., Iba, Y., Horie, S., Terakawa, N. (2004). Hepatocyte Growth Factor/Met System Promotes Endometrial and Endometriotic Stromal Cell Invasion via Autocrine and Paracrine Pathways. J. Clin. Endocrinol. Metab. 89: 823-832 [Abstract] [Full Text]  
  • Chan, P.-C., Chen, Y.-L., Cheng, C.-H., Yu, K.-C., Cary, L. A., Shu, K.-H., Ho, W. L., Chen, H.-C. (2003). Src Phosphorylates Grb2-associated Binder 1 upon Hepatocyte Growth Factor Stimulation. J. Biol. Chem. 278: 44075-44082 [Abstract] [Full Text]  
  • Christensen, J. G., Schreck, R., Burrows, J., Kuruganti, P., Chan, E., Le, P., Chen, J., Wang, X., Ruslim, L., Blake, R., Lipson, K. E., Ramphal, J., Do, S., Cui, J. J., Cherrington, J. M., Mendel, D. B. (2003). A Selective Small Molecule Inhibitor of c-Met Kinase Inhibits c-Met-Dependent Phenotypes in Vitro and Exhibits Cytoreductive Antitumor Activity in Vivo. Cancer Res. 63: 7345-7355 [Abstract] [Full Text]  
  • Shinomiya, N., Vande Woude, G. F. (2003). Suppression of Met Expression: A Possible Cancer Treatment: Commentary re: S. J. Kim et al., Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model. Clin. Cancer Res., 14: 5161-5170, 2003.. Clin. Cancer Res. 9: 5085-5090 [Full Text]  
  • Ma, P. C., Kijima, T., Maulik, G., Fox, E. A., Sattler, M., Griffin, J. D., Johnson, B. E., Salgia, R. (2003). c-MET Mutational Analysis in Small Cell Lung Cancer: Novel Juxtamembrane Domain Mutations Regulating Cytoskeletal Functions. Cancer Res. 63: 6272-6281 [Abstract] [Full Text]  
  • Yu, Y., Merlino, G. (2002). Constitutive c-Met Signaling through a Nonautocrine Mechanism Promotes Metastasis in a Transgenic Transplantation Model. Cancer Res. 62: 2951-2956 [Abstract] [Full Text]  
  • Maulik, G., Kijima, T., Ma, P. C., Ghosh, S. K., Lin, J., Shapiro, G. I., Schaefer, E., Tibaldi, E., Johnson, B. E., Salgia, R. (2002). Modulation of the c-Met/Hepatocyte Growth Factor Pathway in Small Cell Lung Cancer. Clin. Cancer Res. 8: 620-627 [Abstract] [Full Text]  
  • Furge, K. A., Kiewlich, D., Le, P., Vo, M. N., Faure, M., Howlett, A. R., Lipson, K. E., Vande Woude, G. F., Webb, C. P. (2001). Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase. Proc. Natl. Acad. Sci. USA 10.1073/pnas.191067898v1 [Abstract] [Full Text]  
  • Gmyrek, G. A., Walburg, M., Webb, C. P., Yu, H.-M., You, X., Vaughan, E. D., Vande Woude, G. F., Knudsen, B. S. (2001). Normal and Malignant Prostate Epithelial Cells Differ in Their Response to Hepatocyte Growth Factor/Scatter Factor. Am. J. Pathol. 159: 579-590 [Abstract] [Full Text]  
  • Cao, B., Su, Y., Oskarsson, M., Zhao, P., Kort, E. J., Fisher, R. J., Wang, L.-M., Vande Woude, G. F. (2001). Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl. Acad. Sci. USA 98: 7443-7448 [Abstract] [Full Text]  
  • Shaharabany, M., Abramovitch, R., Kushnir, T., Tsarfaty, G., Ravid-Megido, M., Horev, J., Ron, R., Itzchak, Y., Tsarfaty, I. (2001). In Vivo Molecular Imaging of Met Tyrosine Kinase Growth Factor Receptor Activity in Normal Organs and Breast Tumors. Cancer Res. 61: 4873-4878 [Abstract] [Full Text]  
  • Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., Bishop, J. M. (2001). Activation of the Met Receptor by Cell Attachment Induces and Sustains Hepatocellular Carcinomas in Transgenic Mice. JCB 153: 1023-1034 [Abstract] [Full Text]  
  • Tokunou, M., Niki, T., Eguchi, K., Iba, S., Tsuda, H., Yamada, T., Matsuno, Y., Kondo, H., Saitoh, Y., Imamura, H., Hirohashi, S. (2001). c-MET Expression in Myofibroblasts : Role in Autocrine Activation and Prognostic Significance in Lung Adenocarcinoma. Am. J. Pathol. 158: 1451-1463 [Abstract] [Full Text]  
  • Tam, N.N.C., Chung, S.S.M., Lee, D.T.W., Wong, Y.C. (2000). Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat. Carcinogenesis 21: 2183-2191 [Abstract] [Full Text]  
  • Maroun, C. R., Naujokas, M. A., Holgado-Madruga, M., Wong, A. J., Park, M. (2000). The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase. Mol. Cell. Biol. 20: 8513-8525 [Abstract] [Full Text]  
  • Beilmann, M., Vande Woude, G. F., Dienes, H.-P., Schirmacher, P. (2000). Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 95: 3964-3969 [Abstract] [Full Text]  
  • Hanzawa, M., Shindoh, M., Higashino, F., Yasuda, M., Inoue, N., Hida, K., Ono, M., Kohgo, T., Nakamura, M., Notani, K.-i., Fukuda, H., Totsuka, Y., Yoshida, K., Fujinaga, K. (2000). Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21: 1079-1085 [Abstract] [Full Text]  
  • Otsuka, T., Jakubczak, J., Vieira, W., Bottaro, D. P., Breckenridge, D., Larochelle, W. J., Merlino, G. (2000). Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis. Mol. Cell. Biol. 20: 2055-2065 [Abstract] [Full Text]  
  • Webb, C. P., Hose, C. D., Koochekpour, S., Jeffers, M., Oskarsson, M., Sausville, E., Monks, A., Vande Woude, G. F. (2000). The Geldanamycins Are Potent Inhibitors of the Hepatocyte Growth Factor/Scatter Factor-Met-Urokinase Plasminogen Activator-Plasmin Proteolytic Network. Cancer Res. 60: 342-349 [Abstract] [Full Text]  
  • Ried, S., Jager, C., Jeffers, M., Vande Woude, G. F., Graeff, H., Schmitt, M., Lengyel, E. (1999). Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor. J. Biol. Chem. 274: 16377-16386 [Abstract] [Full Text]  
  • Arakaki, N., Kajihara, T., Arakaki, R., Ohnishi, T., Kazi, J. A., Nakashima, H., Daikuhara, Y. (1999). Involvement of Oxidative Stress in Tumor Cytotoxic Activity of Hepatocyte Growth Factor/Scatter Factor. J. Biol. Chem. 274: 13541-13546 [Abstract] [Full Text]  
  • Maroun, C. R., Holgado-Madruga, M., Royal, I., Naujokas, M. A., Fournier, T. M., Wong, A. J., Park, M. (1999). The Gab1 PH Domain Is Required for Localization of Gab1 at Sites of Cell-Cell Contact and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase. Mol. Cell. Biol. 19: 1784-1799 [Abstract] [Full Text]  
  • Ronen, D., Altstock, R. T., Firon, M., Mittelman, L., Sobe, T., Resau, J. H., Vande Woude, G. F., Tsarfaty, I. (1999). Met-HGF/SF Mediates Growth Arrest and Differentiation in T47D Breast Cancer Cells. Cell Growth Differ. 10: 131-140 [Abstract] [Full Text]  
  • Rahimi, N., Hung, W., Tremblay, E., Saulnier, R., Elliott, B. (1998). c-Src Kinase Activity Is Required for Hepatocyte Growth Factor-induced Motility and Anchorage-independent Growth of Mammary Carcinoma Cells. J. Biol. Chem. 273: 33714-33721 [Abstract] [Full Text]  
  • Jeffers, M., Fiscella, M., Webb, C. P., Anver, M., Koochekpour, S., Vande Woude, G. F. (1998). The mutationally activated Met receptor mediates motility and metastasis. Proc. Natl. Acad. Sci. USA 95: 14417-14422 [Abstract] [Full Text]  
  • Trusolino, L., Serini, G., Cecchini, G., Besati, C., Ambesi-Impiombato, F. S., Marchisio, P. C., De Filippi, R. (1998). Growth Factor-dependent Activation of {alpha}v{beta}3 Integrin in Normal Epithelial Cells: Implications for Tumor Invasion. JCB 142: 1145-1156 [Abstract] [Full Text]  
  • Potempa, S., Ridley, A. J. (1998). Activation of Both MAP Kinase and Phosphatidylinositide 3-Kinase by Ras Is Required for Hepatocyte Growth Factor/Scatter Factor-induced Adherens Junction Disassembly. Mol. Biol. Cell 9: 2185-2200 [Abstract] [Full Text]  
  • Webb, C. P., Van Aelst, L., Wigler, M. H., Vande Woude, G. F. (1998). Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. USA 95: 8773-8778 [Abstract] [Full Text]  
  • Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., Vande Woude, G. F. (1997). Activating mutations for the Met tyrosine kinase receptor in human cancer. Proc. Natl. Acad. Sci. USA 94: 11445-11450 [Abstract] [Full Text]  
  • Nguyen, L., Holgado-Madruga, M., Maroun, C., Fixman, E. D., Kamikura, D., Fournier, T., Charest, A., Tremblay, M. L., Wong, A. J., Park, M. (1997). Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356. J. Biol. Chem. 272: 20811-20819 [Abstract] [Full Text]  
  • Schaper, W., Kubin, T. (1997). Is Hepatocyte Growth Factor a Protein With Cardioprotective Activity in the Ischemic Heart?. Circulation 95: 2471-2472 [Full Text]  
  • Anastasi, S., Giordano, S., Sthandier, O., Gambarotta, G., Maione, R., Comoglio, P., Amati, P. (1997). A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic Differentiation. JCB 137: 1057-1068 [Abstract] [Full Text]  
  • Borset, M., Lien, E., Espevik, T., Helseth, E., Waage, A., Sundan, A. (1996). Concomitant Expression of Hepatocyte Growth Factor/Scatter Factor and the Receptor c-MET in Human Myeloma Cell Lines. J. Biol. Chem. 271: 24655-24661 [Abstract] [Full Text]  
  • Fournier, T. M., Kamikura, D., Teng, K., Park, M. (1996). Branching Tubulogenesis but Not Scatter of Madin-Darby Canine Kidney Cells Requires a Functional Grb2 Binding Site in the Met Receptor Tyrosine Kinase. J. Biol. Chem. 271: 22211-22217 [Abstract] [Full Text]  
  • Webb, C., Lane, K, Dawson, A., Vande Woude, G., Warn, R. (1996). C-Met signalling in an HGF/SF-insensitive variant MDCK cell line with constitutive motile/invasive behaviour. J. Cell Sci. 109: 2371-2381 [Abstract]  
  • Royal, I., Park, M. (1995). Hepatocyte Growth Factor-induced Scatter of Madin-Darby Canine Kidney Cells Requires Phosphatidylinositol 3-Kinase. J. Biol. Chem. 270: 27780-27787 [Abstract] [Full Text]  
  • Naldini, L., Vigna, E., Bardelli, A., Follenzi, A., Galimi, F., Comoglio, P. M. (1995). Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction. J. Biol. Chem. 270: 603-611 [Abstract] [Full Text]  
  • Wang, M., Ronsin, C, Gesnel, M., Coupey, L, Skeel, A, Leonard, E., Breathnach, R (1994). Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266: 117-119 [Abstract]  
  • Mansour, S., Matten, W., Hermann, A., Candia, J., Rong, S, Fukasawa, K, Vande Woude, G., Ahn, N. (1994). Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970 [Abstract]  
  • Berdichevsky, F, Alford, D, D'Souza, B, Taylor-Papadimitriou, J (1994). Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci. 107: 3557-3568 [Abstract]  
  • Tsarfaty, I, Rong, S, Resau, J., Rulong, S, da Silva, P., Vande Woude, G. (1994). The Met proto-oncogene mesenchymal to epithelial cell conversion. Science 263: 98-101 [Abstract]  
  • Rong, S., Vande Woude, G.F. (1994). Autocrine Mechanism for met Proto-oncogene Tumorigenicity. Cold Spring Harb Symp Quant Biol 59: 629-636 [Abstract]  
  • Lock, L. S., Royal, I., Naujokas, M. A., Park, M. (2000). Identification of an Atypical Grb2 Carboxyl-terminal SH3 Domain Binding Site in Gab Docking Proteins Reveals Grb2-dependent and -independent Recruitment of Gab1 to Receptor Tyrosine Kinases. J. Biol. Chem. 275: 31536-31545 [Abstract] [Full Text]  
  • Tsukada, Y.-i., Miyazawa, K., Kitamura, N. (2001). High Intensity ERK Signal Mediates Hepatocyte Growth Factor-induced Proliferation Inhibition of the Human Hepatocellular Carcinoma Cell Line HepG2. J. Biol. Chem. 276: 40968-40976 [Abstract] [Full Text]  
  • Furge, K. A., Kiewlich, D., Le, P., Vo, M. N., Faure, M., Howlett, A. R., Lipson, K. E., Woude, G. F. V., Webb, C. P. (2001). Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase. Proc. Natl. Acad. Sci. USA 98: 10722-10727 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»